SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3k1d'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1BDW_B_DVAB6_0
(GRAMICIDIN A)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
3 / 3 TRP A 584
ALA A 582
VAL A 534
None
0.90A 1bdwA-3k1dA:
undetectable
1bdwB-3k1dA:
undetectable
1bdwA-3k1dA:
2.24
1bdwB-3k1dA:
2.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DED_B_QPSB1501_1
(CYCLODEXTRIN
GLUCANOTRANSFERASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
6 / 12 TYR A 306
ARG A 409
ASP A 411
ALA A 412
HIS A 531
ASP A 532
None
0.85A 1dedB-3k1dA:
25.0
1dedB-3k1dA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ESW_A_ACRA651_1
(AMYLOMALTASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
6 / 12 TYR A 306
GLN A 307
GLU A 464
HIS A 531
ASP A 532
TRP A 304
None
1.14A 1eswA-3k1dA:
18.2
1eswA-3k1dA:
22.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GMK_D_DVAD6_0
(GRAMICIDIN A)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 4 VAL A 177
TRP A 152
ALA A 153
VAL A 183
None
1.15A 1gmkC-3k1dA:
undetectable
1gmkD-3k1dA:
undetectable
1gmkC-3k1dA:
2.24
1gmkD-3k1dA:
2.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GXS_C_BEZC602_0
(P-(S)-HYDROXYMANDELO
NITRILE LYASE CHAIN
A
P-(S)-HYDROXYMANDELO
NITRILE LYASE CHAIN
B)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 9 PRO A 344
ASP A 411
HIS A 346
MET A 416
ALA A 412
None
1.25A 1gxsC-3k1dA:
0.0
1gxsD-3k1dA:
0.0
1gxsC-3k1dA:
16.97
1gxsD-3k1dA:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NH8_A_HISA289_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 5 ASP A 102
LEU A  83
ALA A  57
LEU A  88
None
1.01A 1nh8A-3k1dA:
undetectable
1nh8A-3k1dA:
18.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XP0_A_VDNA201_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 10 LEU A 392
ALA A 396
VAL A 410
ALA A 463
PHE A 444
None
0.91A 1xp0A-3k1dA:
undetectable
1xp0A-3k1dA:
18.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZEA_A_DHIA6_0
(MONOCLONAL
ANTI-CHOLERA TOXIN
IGG1 KAPPA ANTIBODY,
H CHAIN
MONOCLONAL
ANTI-CHOLERA TOXIN
IGG1 KAPPA ANTIBODY,
L CHAIN
SHORT SYNTHETIC
D-AMINO ACID PEPTIDE
D2)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
3 / 3 TRP A 727
ARG A 648
PHE A 646
None
1.40A 1zeaH-3k1dA:
4.0
1zeaL-3k1dA:
2.3
1zeaH-3k1dA:
14.52
1zeaL-3k1dA:
14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2B9E_A_SAMA1201_0
(NOL1/NOP2/SUN DOMAIN
FAMILY, MEMBER 5
ISOFORM 2)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 12 GLY A 111
ARG A 135
ASP A 213
PHE A 215
PHE A 217
None
1.34A 2b9eA-3k1dA:
undetectable
2b9eA-3k1dA:
18.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HA4_A_ACHA546_0
(ACETYLCHOLINESTERASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 8 TRP A 491
TYR A 631
TYR A 562
PHE A 660
None
1.15A 2ha4A-3k1dA:
undetectable
2ha4A-3k1dA:
23.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HS2_B_017B203_1
(PROTEASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 6 PRO A 730
LEU A 674
ARG A 681
GLY A 701
None
1.08A 2hs2B-3k1dA:
undetectable
2hs2B-3k1dA:
9.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2J2P_B_SC2B1290_1
(FICOLIN-2)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 8 LEU A 720
SER A 724
ASP A 687
GLU A 682
None
1.07A 2j2pA-3k1dA:
undetectable
2j2pB-3k1dA:
undetectable
2j2pA-3k1dA:
15.08
2j2pB-3k1dA:
15.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OAX_E_SNLE5001_1
(MINERALOCORTICOID
RECEPTOR)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 12 LEU A 644
ALA A 565
LEU A 527
MET A 513
LEU A 559
None
1.19A 2oaxE-3k1dA:
undetectable
2oaxE-3k1dA:
16.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OWC_A_ACRA600_1
(4-ALPHA-GLUCANOTRANS
FERASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
6 / 11 TYR A 306
GLN A 307
ASP A 411
HIS A 531
ASP A 532
TRP A 304
None
1.19A 2owcA-3k1dA:
17.8
2owcA-3k1dA:
23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OWW_A_ACRA600_1
(4-ALPHA-GLUCANOTRANS
FERASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
6 / 11 TYR A 306
GLN A 307
ASP A 411
HIS A 531
ASP A 532
TRP A 304
None
1.19A 2owwA-3k1dA:
4.6
2owwA-3k1dA:
23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QE6_A_SAMA400_1
(UNCHARACTERIZED
PROTEIN TFU_2867)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
3 / 3 ASN A  29
ARG A 176
ASP A 102
None
0.61A 2qe6A-3k1dA:
undetectable
2qe6A-3k1dA:
17.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QE6_B_SAMB400_1
(UNCHARACTERIZED
PROTEIN TFU_2867)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
3 / 3 ASN A  29
ARG A 176
ASP A 102
None
0.61A 2qe6B-3k1dA:
undetectable
2qe6B-3k1dA:
17.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XAD_E_GCSE710_1
(N-ACYL GLM
PEUDO-TEICOPLANIN
DEACETYLASE
TEICOPLANIN)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 8 ASP A 687
SER A 694
ILE A 696
HIS A 550
None
1.04A 2xadA-3k1dA:
undetectable
2xadA-3k1dA:
18.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XAD_F_GCSF710_1
(N-ACYL GLM
PEUDO-TEICOPLANIN
DEACETYLASE
TEICOPLANIN)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 8 ASP A 687
SER A 694
ILE A 696
HIS A 550
None
1.06A 2xadB-3k1dA:
undetectable
2xadB-3k1dA:
18.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XAD_G_GCSG710_1
(N-ACYL GLM
PEUDO-TEICOPLANIN
DEACETYLASE
TEICOPLANIN)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 8 ASP A 687
SER A 694
ILE A 696
HIS A 550
None
1.01A 2xadC-3k1dA:
undetectable
2xadC-3k1dA:
18.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XAD_H_GCSH710_1
(N-ACYL GLM
PEUDO-TEICOPLANIN
DEACETYLASE
TEICOPLANIN)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 8 ASP A 687
SER A 694
ILE A 696
HIS A 550
None
1.03A 2xadD-3k1dA:
undetectable
2xadD-3k1dA:
18.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XRZ_A_ACTA1469_0
(DEOXYRIBODIPYRIMIDIN
E PHOTOLYASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 4 GLN A 273
GLU A 277
LEU A 269
SER A 270
None
1.40A 2xrzA-3k1dA:
1.0
2xrzA-3k1dA:
22.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AIC_C_ACRC5044_1
(GLUCOSYLTRANSFERASE-
SI)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
6 / 12 ARG A 409
ASP A 411
ALA A 412
HIS A 531
ASP A 532
TYR A 306
None
0.98A 3aicC-3k1dA:
2.6
3aicC-3k1dA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AY0_A_ADNA401_1
(UNCHARACTERIZED
PROTEIN MJ0883)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 10 PHE A 149
ASP A 213
VAL A 229
LEU A 161
PHE A 191
None
1.25A 3ay0A-3k1dA:
undetectable
3ay0A-3k1dA:
17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AY0_B_ADNB402_1
(UNCHARACTERIZED
PROTEIN MJ0883)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 10 PHE A 149
ASP A 213
VAL A 229
LEU A 161
PHE A 191
None
1.24A 3ay0B-3k1dA:
undetectable
3ay0B-3k1dA:
17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S8P_A_SAMA500_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV420H1)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 12 GLY A 131
ALA A 132
SER A 310
PHE A 403
GLU A 402
None
1.45A 3s8pA-3k1dA:
undetectable
3s8pA-3k1dA:
15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S8P_B_SAMB500_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV420H1)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 12 GLY A 131
ALA A 132
SER A 310
PHE A 403
GLU A 402
None
1.43A 3s8pB-3k1dA:
undetectable
3s8pB-3k1dA:
15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SXJ_A_SAMA258_0
(PUTATIVE
METHYLTRANSFERASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 12 ARG A 581
GLY A 579
GLN A 594
LEU A 607
GLU A 597
None
1.10A 3sxjA-3k1dA:
undetectable
3sxjA-3k1dA:
15.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SXJ_B_SAMB258_0
(PUTATIVE
METHYLTRANSFERASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 12 ARG A 581
GLY A 579
GLN A 594
LEU A 607
GLU A 597
None
1.11A 3sxjB-3k1dA:
undetectable
3sxjB-3k1dA:
15.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TZF_B_08DB280_1
(7,8-DIHYDROPTEROATE
SYNTHASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 8 ARG A 176
PRO A  30
GLY A 158
SER A 160
None
1.11A 3tzfB-3k1dA:
9.2
3tzfB-3k1dA:
18.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V5W_A_8PRA701_2
(G-PROTEIN COUPLED
RECEPTOR KINASE 2)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
3 / 3 LEU A 728
MET A 647
ASP A 635
None
0.88A 3v5wA-3k1dA:
undetectable
3v5wA-3k1dA:
22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WSJ_A_MK1A201_1
(PROTEASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 9 LEU A 400
VAL A 340
LEU A 292
TRP A 399
ILE A 405
None
1.42A 3wsjA-3k1dA:
undetectable
3wsjA-3k1dA:
10.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BLV_A_SAMA1281_0
(RIBOSOMAL RNA LARGE
SUBUNIT
METHYLTRANSFERASE J)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 12 LEU A 327
GLY A 319
LEU A 274
ASP A 323
GLY A 263
None
1.09A 4blvA-3k1dA:
undetectable
4blvA-3k1dA:
17.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BUP_A_SAMA500_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV420H1)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 12 GLY A 131
ALA A 132
SER A 310
PHE A 403
GLU A 402
None
1.44A 4bupA-3k1dA:
undetectable
4bupA-3k1dA:
15.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BUP_B_SAMB500_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV420H1)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 12 GLY A 131
ALA A 132
SER A 310
PHE A 403
GLU A 402
None
1.46A 4bupB-3k1dA:
undetectable
4bupB-3k1dA:
15.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_B_RKEB401_1
(PROTON-GATED ION
CHANNEL)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 8 ASP A  62
VAL A  76
PHE A  80
LEU A  83
None
1.06A 4f8hB-3k1dA:
undetectable
4f8hC-3k1dA:
undetectable
4f8hB-3k1dA:
18.13
4f8hC-3k1dA:
18.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_C_RKEC401_1
(PROTON-GATED ION
CHANNEL)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 8 ASP A  62
VAL A  76
PHE A  80
LEU A  83
None
1.09A 4f8hC-3k1dA:
undetectable
4f8hD-3k1dA:
undetectable
4f8hC-3k1dA:
18.13
4f8hD-3k1dA:
18.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_D_RKED401_1
(PROTON-GATED ION
CHANNEL)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 8 ASP A  62
VAL A  76
PHE A  80
LEU A  83
None
1.09A 4f8hD-3k1dA:
undetectable
4f8hE-3k1dA:
undetectable
4f8hD-3k1dA:
18.13
4f8hE-3k1dA:
18.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F8H_E_RKEE401_1
(PROTON-GATED ION
CHANNEL)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 8 VAL A  76
PHE A  80
LEU A  83
ASP A  62
None
1.08A 4f8hA-3k1dA:
undetectable
4f8hE-3k1dA:
undetectable
4f8hA-3k1dA:
18.13
4f8hE-3k1dA:
18.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LV9_A_20JA601_1
(NICOTINAMIDE
PHOSPHORIBOSYLTRANSF
ERASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 8 ASP A 420
ALA A 414
SER A 466
TYR A 418
None
1.15A 4lv9A-3k1dA:
2.8
4lv9B-3k1dA:
3.6
4lv9A-3k1dA:
20.28
4lv9B-3k1dA:
20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LV9_B_20JB601_1
(NICOTINAMIDE
PHOSPHORIBOSYLTRANSF
ERASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 7 TYR A 418
ASP A 420
ALA A 414
SER A 466
None
1.17A 4lv9A-3k1dA:
2.8
4lv9B-3k1dA:
3.6
4lv9A-3k1dA:
20.28
4lv9B-3k1dA:
20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TZU_B_Y70B505_1
(PROTEIN CEREBLON)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 7 HIS A 123
TRP A 127
PHE A 217
THR A 451
None
1.42A 4tzuB-3k1dA:
1.0
4tzuC-3k1dA:
1.0
4tzuB-3k1dA:
8.86
4tzuC-3k1dA:
8.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4W5Q_A_IPHA903_0
(PROTEIN ARGONAUTE-2)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 5 TYR A 363
PRO A 348
LEU A 392
TYR A 311
None
1.38A 4w5qA-3k1dA:
1.6
4w5qA-3k1dA:
22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WAN_C_ACTC303_0
(BRANCHPOINT-BRIDGING
PROTEIN)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
3 / 3 ASP A 367
ARG A 356
PRO A 361
None
0.82A 4wanC-3k1dA:
undetectable
4wanC-3k1dA:
10.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNW_B_RTZB602_1
(CYTOCHROME P450 2D6)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 12 LEU A 354
GLY A 131
LEU A 130
VAL A 183
VAL A 388
None
0.99A 4wnwB-3k1dA:
undetectable
4wnwB-3k1dA:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WRZ_A_URFA302_1
(URACIL-DNA
GLYCOSYLASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 8 GLY A 131
TYR A 398
PHE A 217
HIS A 133
None
1.04A 4wrzA-3k1dA:
undetectable
4wrzA-3k1dA:
16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WS0_A_URFA301_1
(URACIL-DNA
GLYCOSYLASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 7 GLY A 131
TYR A 398
PHE A 217
HIS A 133
None
1.03A 4ws0A-3k1dA:
undetectable
4ws0A-3k1dA:
16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WS1_A_URFA301_1
(URACIL-DNA
GLYCOSYLASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 8 GLY A 131
TYR A 398
PHE A 217
HIS A 133
None
1.03A 4ws1A-3k1dA:
undetectable
4ws1A-3k1dA:
16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_A_HISA302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 10 GLY A 182
GLU A 387
VAL A 183
LEU A 362
LEU A 130
None
1.20A 4yb6A-3k1dA:
undetectable
4yb6E-3k1dA:
undetectable
4yb6A-3k1dA:
16.85
4yb6E-3k1dA:
16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_B_HISB302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 10 GLY A 182
GLU A 387
VAL A 183
LEU A 362
LEU A 130
None
1.19A 4yb6B-3k1dA:
undetectable
4yb6C-3k1dA:
undetectable
4yb6B-3k1dA:
16.85
4yb6C-3k1dA:
16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_C_HISC302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 10 GLY A 182
GLU A 387
VAL A 183
LEU A 362
LEU A 130
None
1.19A 4yb6C-3k1dA:
undetectable
4yb6F-3k1dA:
undetectable
4yb6C-3k1dA:
16.85
4yb6F-3k1dA:
16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_D_HISD302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 10 LEU A 362
LEU A 130
GLY A 182
GLU A 387
VAL A 183
None
1.20A 4yb6A-3k1dA:
undetectable
4yb6D-3k1dA:
undetectable
4yb6A-3k1dA:
16.85
4yb6D-3k1dA:
16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_E_HISE302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 10 LEU A 362
LEU A 130
GLY A 182
GLU A 387
VAL A 183
None
1.19A 4yb6D-3k1dA:
undetectable
4yb6E-3k1dA:
undetectable
4yb6D-3k1dA:
16.85
4yb6E-3k1dA:
16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_F_HISF302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 10 LEU A 362
LEU A 130
GLY A 182
GLU A 387
VAL A 183
None
1.18A 4yb6B-3k1dA:
undetectable
4yb6F-3k1dA:
undetectable
4yb6B-3k1dA:
16.85
4yb6F-3k1dA:
16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CPR_B_SAMB402_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV420H1)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 12 GLY A 131
ALA A 132
SER A 310
PHE A 403
GLU A 402
None
1.39A 5cprB-3k1dA:
undetectable
5cprB-3k1dA:
15.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HQA_A_ACRA705_2
(ALPHA-GLUCOSIDASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 8 ASN A 395
PHE A 381
HIS A 298
THR A 461
None
1.44A 5hqaA-3k1dA:
15.9
5hqaA-3k1dA:
22.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JDC_A_6JPA302_1
(PTERIDINE REDUCTASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 10 SER A 522
MET A 492
TYR A 519
PRO A 468
HIS A 493
None
1.25A 5jdcA-3k1dA:
1.8
5jdcD-3k1dA:
1.7
5jdcA-3k1dA:
17.24
5jdcD-3k1dA:
17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JDC_C_6JPC302_1
(PTERIDINE REDUCTASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 10 HIS A 493
SER A 522
MET A 492
TYR A 519
PRO A 468
None
1.23A 5jdcB-3k1dA:
1.8
5jdcC-3k1dA:
1.7
5jdcB-3k1dA:
17.24
5jdcC-3k1dA:
17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JDC_D_6JPD302_1
(PTERIDINE REDUCTASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 11 HIS A 493
SER A 522
MET A 492
TYR A 519
PRO A 468
None
1.22A 5jdcA-3k1dA:
1.1
5jdcD-3k1dA:
undetectable
5jdcA-3k1dA:
17.24
5jdcD-3k1dA:
17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M5C_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 10 VAL A 159
LEU A 362
ALA A 153
GLY A 131
LEU A 130
None
1.28A 5m5cE-3k1dA:
undetectable
5m5cE-3k1dA:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_A_ZOLA401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 7 ASP A 591
ARG A 588
GLN A 594
GLN A 576
None
1.50A 6g31A-3k1dA:
undetectable
6g31A-3k1dA:
7.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_B_ZOLB401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 6 ASP A 591
ARG A 588
GLN A 594
GLN A 576
None
1.37A 6g31B-3k1dA:
undetectable
6g31B-3k1dA:
7.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_F_ZOLF401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 5 ASP A 591
ARG A 588
GLN A 594
GLN A 576
None
1.46A 6g31F-3k1dA:
undetectable
6g31F-3k1dA:
7.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_L_ZOLL401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
4 / 6 ASP A 591
ARG A 588
GLN A 594
GLN A 576
None
1.27A 6g31L-3k1dA:
undetectable
6g31L-3k1dA:
7.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HUP_D_DZPD2001_0
(GAMMA-AMINOBUTYRIC
ACID RECEPTOR
SUBUNIT
ALPHA-1,GAMMA-AMINOB
UTYRIC ACID RECEPTOR
SUBUNIT ALPHA-1
GAMMA-AMINOBUTYRIC
ACID RECEPTOR
SUBUNIT GAMMA-2)
3k1d 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME

(Mycobacterium
tuberculosis)
5 / 9 ASN A 395
PHE A 391
PHE A 381
TYR A 363
VAL A 308
None
1.43A 6hupC-3k1dA:
1.9
6hupD-3k1dA:
1.1
6hupC-3k1dA:
6.83
6hupD-3k1dA:
7.64